STE

STERIS plc

Healthcare · $20.4B market cap

Verdict

Share price

$208.54

close of Oct 3, 2026

Fair value

$234.19

Sticker Price

Payback Price

$93.68

buy price

Undervalued

STE is Undervalued: at $208.54 it trades 11% below its fair value of $234.19. Its buy price (Payback Price) is $93.68, 55% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 9% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth11.4% a year✓
Equity per share growth11.5% a year✓
Sales growth9.7% a year✗
Free cash flow growth14.4% a year✓
Return on invested capital7.4%✗

Follow STE

Get notified when it reaches its buy price of $93.68. Free.

Create a free account

Superinvestors

1 of the investors we track holds STE. In Q2 2026, 1 added. Who we track

Moves in Q2 2026

Added: First Eagle Investment Management

Insider activity

Since Jun 15, 2026: no open-market purchases, 2 sales worth $1.3M and 16 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It…

Medical - Specialties

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works